HomeClinical TopicsPretreatment with Intralipid may reduce side effects of platinum-containing chemotherapy
Clinical TopicsDrugs and DevicesWeb Exclusives

Pretreatment with Intralipid may reduce side effects of platinum-containing chemotherapy

Pretreatment with a single dose of Intralipid may reduce side effects of platinum-containing chemotherapy while increasing bioavailability, according to a study in Scientific Reports. Read more.

Previous articleInternational Home Care Nurses Organization conference
Next articleFDA approves drug for rare lung disease

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content

For Nurse Practitioners

Women suffering from a migraine

Quiz: Migraines and Hormones

Women are 2 to 3 times more likely than men to have migraines.  Decades ago, these were attributed to women’s inability to cope with...

Powered by  HCM   www.HealthComMedia.com

© 2022 HealthCom Media All rights reserved. No part of this website or publication may be reproduced, stored, or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the copyright holder.